
ELEV
Healthcare · Biotechnology · $21.6M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2025
EPS trend, 90 days to now · -53.3% over 90 days · 30-day revisions 0 up, 3 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 6, 2025 | Time not confirmed | -0.13 | 0.00 | +100.0% |
| Aug 6, 2025 | Time not confirmed | -0.22 | 0.00 | +100.0% |
| May 14, 2025 | Time not confirmed | -0.20 | -0.24 | -20.0% |
| Mar 6, 2025 | Time not confirmed | -0.22 | -0.18 | +18.2% |
| Nov 6, 2024 | Time not confirmed | -0.19 | -0.22 | -15.8% |
| Aug 6, 2024 | Time not confirmed | -0.22 | -0.18 | +18.2% |
| May 2, 2024 | Before the open | -0.20 | -0.23 | -15.0% |
| Mar 6, 2024 | Before the open | -0.24 | -0.19 | +20.8% |
| Nov 2, 2023 | Before the open | -0.32 | -0.25 | +21.9% |
| Aug 3, 2023 | Before the open | -0.32 | -0.37 | -15.6% |
| May 15, 2023 | Before the open | -0.59 | -0.72 | -22.0% |
| Mar 9, 2023 | Before the open | -0.78 | -0.82 | -5.1% |
| Nov 3, 2022 | Before the open | -1.30 |
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. It's lead candidate is EO-3021, an antibody-drug conjugate (ADC) comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic…
| -1.67 |
| -28.5% |
| Aug 4, 2022 | Before the open | -0.79 | -0.86 | -8.9% |
| May 5, 2022 | Before the open | -0.50 | -0.74 | -48.0% |
| Mar 3, 2022 | Before the open | -0.59 | -0.41 | +30.5% |
| Nov 12, 2021 | Before the open | -0.38 | -0.53 | -39.5% |
| Aug 12, 2021 | After the close | -2.82 | -4.84 | -71.6% |
| Jun 25, 2021 | After the close | -0.71 | -0.91 | -27.8% |
| Mar 31, 2021 | Time not confirmed | 0.00 | -1.50 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.59 | — |